Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CDCA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112341512A details a novel route converting seal cholic acid to chenodeoxycholic acid, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply reliability.
Patent CN120081889B reveals a one-pot hydrogenation method for high-purity chenodeoxycholic acid, offering significant cost reduction in API manufacturing and scalable production.
Patent CN107573396B details a novel two-step chromatography method achieving >97.5% purity CDCA. Ideal for reliable pharmaceutical intermediates supply chains.
Novel patent CN104558086B details high-yield 6-ECDCA synthesis offering supply chain stability and cost reduction in API manufacturing for global partners.
Patent CN105418716A details a novel duck bile extraction method for Chenodeoxycholic acid. This process ensures high purity and significant cost reduction for pharmaceutical intermediates manufacturing supply chains.
Patent CN106478757A details improved 6α-ECDCA synthesis. Delivers high yield and mild conditions for global pharmaceutical supply chains.
Patent CN106478757A reveals a mild synthesis for 6α-ECDCA. This report analyzes cost reduction in API manufacturing and supply chain reliability for global buyers.
Advanced synthesis of Chenodeoxycholic Acid via hypochlorite oxidation. High yield, low cost route for API manufacturing. Reliable pharmaceutical intermediates supplier.
Novel silane-protection route for Obeticholic Acid reduces impurities and enhances scalability for pharmaceutical manufacturing.
Patent CN104876995B details a 5-step Swern oxidation route for 6ECDCA. Offers high purity, reduced waste, and scalable manufacturing for global supply chains.
Patent CN106831923B reveals a novel CDCA synthesis route. Discover high-purity manufacturing, supply chain reliability, and significant cost reduction strategies.
Novel patent CN112724189B details waste-to-value synthesis enhancing supply chain reliability and cost efficiency for global pharmaceutical intermediate procurement strategies.
Patent CN112724189A details a novel semi-synthetic route for Chenodeoxycholic Acid from waste bile acids, offering significant cost reduction and supply chain stability for API manufacturers.